SenesTech

SenesTech, Inc. engages in the development and commercialization of proprietary technology for the management of animal pest populations, primarily rat populations through fertility control. It offers its ContraPest product to residential, and commercial sectors such as animal, structural, and food markets. The company was founded by Loretta P. Mayer and Cheryl A. Dyer on July 27, 2004 and is headquartered in Phoenix, AZ.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

SenesTech reports record revenue growth driven by Evolve product launch

SenesTech's Q1 2024 performance was driven by the successful launch of Evolve, leading to record revenue growth. The company's strengths lie in expanding distribution channels and focusing on operational efficiencies. Challenges include achieving positive cash flow and balancing sales channels, while opportunities exist in capturing a larger market share with Evolve mouse and leveraging the Amazon store launch.

SenesTech achieves record revenue and margin growth, eyes global expansion

SenesTech delivered strong financial performance with record revenue and improved margins.
The company's product portfolio and expansion strategies position it for continued growth.
Challenges include maintaining profitability, managing competition, and balancing growth with financial stability.
Opportunities exist in market penetration, partnerships, and global expansion initiatives.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

SenesTech, Inc. engages in the development and commercialization of proprietary technology for the management of animal pest populations. The firm focuses on rat populations through fertility control. It offers its ContraPest product to residential and commercial sectors such as animal, structural, and food markets. The company was founded by Loretta P. Mayer and Cheryl A. Dyer on July 27, 2004 and is headquartered in Phoenix, AZ.

SenesTech, Inc. (SNES) CEO Ken Siegel on Q4 2020 Results - Earnings Call Transcript

PHOENIX, March 25, 2021 /PRNewswire/ -- SenesTech, Inc. (NASDAQ: SNES), a developer of proprietary, next generation technologies for managing animal pest populations through fertility control, today announced financial and operational results for the fourth quarter and fiscal year 2020, which ended on December 31, 2020. Ken Siegel, CEO of SenesTech, commented, "We made significant progress in 2020 in building awareness and adoption of ContraPest, as evidenced by a 97% year-over-year increase in revenue.

SenesTech Announces Year End 2020 Financial and Operational Results

PHOENIX, March 24, 2021 /PRNewswire/ -- SenesTech, Inc. (NASDAQ: SNES), a developer of proprietary, next generation technologies for managing animal pest populations through fertility control, today announced the initiation of a collaboration with Liphatech, Inc., a global leader in the research, manufacturing and distribution of innovative pest control products, to develop a non-liquid formulation of ContraPest®. Both companies will be contributing resources to the project.

SenesTech Announces Collaboration with Liphatech to Develop a New Non-Liquid Formulation of ContraPest®

PHOENIX, March 23, 2021 /PRNewswire/ -- SenesTech, Inc. (NASDAQ: SNES), a developer of proprietary, next generation technologies for managing animal pest populations through fertility control, announced today that it will present at the Lytham Partners Spring 2021 Investor Conference on Wednesday, March 31, 2021 at 12:30pm ET. A webcast of the presentation will be available on the Company's website at https://senestech.investorroom.com/ or https://www.webcaster4.com/Webcast/Page/1621/40331.

SenesTech to Present at the Lytham Partners Spring 2021 Investor Conference

PHOENIX, March 23, 2021 (GLOBE NEWSWIRE) -- SenesTech, Inc. (NASDAQ: SNES), a developer of proprietary, next generation technologies for managing animal pest populations through fertility control, today announced the closing of its previously announced registered direct offering priced at-the-market under Nasdaq rules of 1,975,000 shares of its common stock at a purchase price of $2.00 per share for gross proceeds of $3.95 million.

SenesTech, Inc. Announces Closing of $3.95 Million Registered Direct Offering of Common Stock Priced At-the-Market under Nasdaq Rules

PHOENIX, March 22, 2021 /PRNewswire/ -- SenesTech, Inc. (NASDAQ: SNES), a developer of proprietary, next generation technologies for managing animal pest populations through fertility control, today announced the results of a long-term study of a deployment of ContraPest® in a large, east coast urban setting, with demonstrated, sustained success in reducing rat populations. Data collected from cameras showed that Site A had a 94% reduction in rat activity and a 98% decline in juvenile rat photos since the start of monitoring.

SenesTech Announces Successful Completion of a Long Term Study of an Urban Deployment of ContraPest®

The stock price of SenesTech, Inc. (NASDAQ: SNES) fell by over 10% pre-market. This is why it happened.

SNES Stock Price Falls Over 10% Pre-Market: Why It Happened

Idera Pharmaceuticals

China Rapid Finance

Even the best penny stocks have their dog days. Here's a celebration of this week's weirdest plays: SNES, IDRA, SOS, TSNPD and HLLPF.

Tomslist: The 5 Weirdest Penny Stock Stories of the Week

Enphase Energy

One of the most common questions traders have about stocks is “Why Is It Moving?” That's why Benzinga created the Why Is It Moving, or WIIM, feature in Benzinga Pro.

What Happened With ENPH Stock And SNES Stock This Morning?

PHOENIX, March 19, 2021 /PRNewswire/ -- SenesTech, Inc. (NASDAQ: SNES), a developer of proprietary, next generation technologies for managing animal pest populations through fertility control, today announced that it has entered into securities purchase agreements with several institutional investors for the purchase and sale of 1,975,000 shares of its common stock at a purchase price of $2.00 per share for gross proceeds of $3.95 million, in a registered direct offering priced at-the-market under Nasdaq rules. The offering is expected to close on or about March 23, 2021, subject to satisfaction of customary closing conditions.

SenesTech, Inc. Announces $3.95 Million Registered Direct Offering of Common Stock Priced At-the-Market under Nasdaq Rules

SenesTech (SNES) stock is flying high on Friday after announcing successful trials of its new pest control products at poultry facilities. The post SNES Stock News: Why Biotech Company SenesTech Is Skyrocketing Today appeared first on InvestorPlace.

SNES Stock News: Why Biotech Company SenesTech Is Skyrocketing Today

Shares of SenesTech soared as much as 173% on Friday after the company concluded that its pest control solution demonstrated success in two agricultural deployments. ContraPest, which is a bait system designed to reduce rat populations in agricultural settings, saw positive results within six months of deployment, according to the company.

SenesTech soars 173% after concluding successful deployments of its ContraPest agricultural technology (SENS)

The stock price of SenesTech Inc (NASDAQ: SNES) has increased by over 80% pre-market. This is why it happened.

SNES Stock Price Increases Over 80% Pre-Market: Why It Happened

PHOENIX, March 18, 2021 /PRNewswire/ -- SenesTech, Inc. (NASDAQ: SNES), a developer of proprietary, next generation technologies for managing animal pest populations through fertility control, today announced the conclusion of agricultural deployments of ContraPest® with demonstrated, sustained success in reducing rat populations and improving operating economies in poultry settings. Rats in poultry facilities cause significant damage and can be hazardous to the health of flocks due to disease transmission, equipment impairment, pullet predation, loss of grain, and, in severe cases, may interrupt production.

SenesTech Announces Successful Completion of a Long Term Agricultural Deployment of ContraPest®

PHOENIX, March 17, 2021 /PRNewswire/ -- SenesTech, Inc. (NASDAQ: SNES), a developer of proprietary technologies for managing animal pest populations through fertility control, will report financial results for its fourth quarter and fiscal year 2020, ended December 31, 2020, after the market close on Thursday, March 25, 2021. The Company has scheduled a conference call that same day, Thursday, March 25, 2021, at 5:00 pm ET, to review the results.

SenesTech to Report Fourth Quarter and Fiscal Year 2020 Financial Results on Thursday, March 25, 2021

PHOENIX, Feb. 2, 2021 /PRNewswire/ -- SenesTech, Inc. (NASDAQ: SNES), a developer of proprietary, next generation technologies for managing animal pest populations through fertility control, today announced the closing of its previously announced private placement of 4,388,854 shares of...

SenesTech, Inc. Announces Closing of $10 Million Private Placement Priced At-the-Market

PHOENIX, Jan. 27, 2021 /PRNewswire/ -- SenesTech, Inc. (NASDAQ: SNES), a developer of proprietary, next generation technologies for managing animal pest populations through fertility control, today announced that it has entered into securities purchase agreements with certain...

SenesTech, Inc. Announces $10 Million Private Placement Priced At-the-Market

SenesTech, Inc. (SNES) CEO Ken Siegel on Q3 2020 Results - Earnings Call Transcript

PHOENIX, Nov. 11, 2020 /PRNewswire/ -- SenesTech, Inc. (NASDAQ: SNES), a developer of proprietary, next generation technologies for managing animal pest populations through fertility control, today announced financial and operational results for the third quarter of fiscal year 2020,...

SenesTech Announces Third Quarter 2020 Financial and Operational Results

PHOENIX, Nov. 11, 2020 /PRNewswire/ -- SenesTech, Inc. (NASDAQ: SNES), a developer of proprietary technologies for managing animal pest populations through fertility control, today announced that it has elected three new directors to its Board of Directors, in a move to position the Board...

SenesTech Restructures Board for Commercial Growth

PHOENIX, Nov. 4, 2020 /PRNewswire/ -- SenesTech, Inc. (NASDAQ: SNES), a developer of proprietary technologies for managing animal pest populations through fertility control, will report financial results for its third quarter 2020, ended September 30, 2020, after the market close on...

SenesTech to Report Third Quarter 2020 Financial Results on Wednesday, November 11, 2020

PHOENIX, Sept. 24, 2020 /PRNewswire/ -- SenesTech, Inc. (NASDAQ: SNES), a developer of proprietary technologies for managing animal pest populations through fertility control, is scheduled to participate in a virtual presentation and fireside chat at the October 2020 Lytham Partners...

SenesTech to Present at the October 2020 Lytham Partners Virtual Investor Growth Conference

Delcath Systems

Wall Street recommends to buy shares of SenesTech Inc (NASDAQ:SNES) and Delcath Systems Inc (NASDAQ:DCTH), even though these two stocks have disappointed so much over the prior 52 weeks through Monday, Aug.

Wall Street Recommends Buying These 2 Falling Knives

SenesTech, Inc. (SNES) CEO Kenneth Siegel on Q2 2020 Results - Earnings Call Transcript

PHOENIX, Aug. 12, 2020 /PRNewswire/ -- SenesTech, Inc.

News for SenesTech Stock (SNES)